Gadoterate meglumine

Gadoterate meglumine · Slate Run Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Gadoterate meglumine, covering 2022-04-11 to 2026-08-10. Get the full timeline:

Most recent: FDA Approved: GADOTERATE MEGLUMINE — Original Application (VIWIT PHARM)